• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型放射增敏剂钆克沙卟啉单次高剂量给药导致的可逆性肾毒性。

Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.

作者信息

Rosenthal D I, Becerra C R, Toto R D, Carbone D P, Frenkel E P

机构信息

Department of Radiation Oncology, University of Pennsylvania Medical Center, Philadelphia 19104-4283, USA.

出版信息

Am J Clin Oncol. 2000 Dec;23(6):593-8. doi: 10.1097/00000421-200012000-00013.

DOI:10.1097/00000421-200012000-00013
PMID:11202804
Abstract

Gadolinium (III) texaphyrin (Gd-Tex) (NSC 695238) is a potential radiation sensitizer that selectively localizes in tumors and is detectable by magnetic resonance imaging (MRI). In this single-dose phase I trial, reversible renal injury was the dose-limiting toxicity. This report details that renal injury. A single intravenous dose of Gd-Tex was followed 2 hours later by radiation therapy. The Gd-Tex dose was escalated in 13 patient cohorts. Doses ranged from 0.6 to 29.6 mg/kg. The maximum tolerated dosage (MTD) was 22.3 mg/kg. Three patients had grade II and one had grade III acute nonoliguric renal failure at the 22.3 and 29.6 mg/kg dose levels. The injury was always transient, and responded to fluid restriction and renal diet. In all patients, transient green discoloration including urine developed at doses > or =7.1 mg/kg. MRI studies demonstrated image enhancement in the liver, kidneys, and in primary and metastatic tumors in all patients receiving >5.4 mg/kg. It is important that the liver and kidneys be excluded from the radiation volume. Gd-Tex was well tolerated at doses below the MTD. It is important that the liver and kidneys be excluded from the radiation volume. We recommend that 16.7 mg/kg be used as the maximum single dose to obviate even low grade renal toxicity.

摘要

钆(III) texaphyrin(Gd-Tex)(NSC 695238)是一种潜在的辐射增敏剂,可选择性地定位于肿瘤中,并可通过磁共振成像(MRI)检测到。在这项单剂量I期试验中,可逆性肾损伤是剂量限制性毒性。本报告详细描述了这种肾损伤情况。静脉注射单剂量的Gd-Tex后2小时进行放射治疗。在13个患者队列中逐步增加Gd-Tex剂量。剂量范围为0.6至29.6mg/kg。最大耐受剂量(MTD)为22.3mg/kg。在22.3和29.6mg/kg剂量水平下,3例患者出现II级急性非少尿性肾衰竭,1例出现III级急性非少尿性肾衰竭。损伤总是短暂的,通过限制液体摄入和肾脏饮食可缓解。所有剂量≥7.1mg/kg的患者均出现包括尿液在内的短暂绿色变色。MRI研究表明,所有接受>5.4mg/kg剂量的患者肝脏、肾脏以及原发性和转移性肿瘤均有图像增强。将肝脏和肾脏排除在放射野之外很重要。在低于MTD的剂量下,Gd-Tex耐受性良好。将肝脏和肾脏排除在放射野之外很重要。我们建议将16.7mg/kg用作最大单剂量,以避免即使是低级别肾毒性的发生。

相似文献

1
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.新型放射增敏剂钆克沙卟啉单次高剂量给药导致的可逆性肾毒性。
Am J Clin Oncol. 2000 Dec;23(6):593-8. doi: 10.1097/00000421-200012000-00013.
2
A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.钆特沙卟啉(Gd-Tex)的I期单剂量试验,Gd-Tex是一种可通过磁共振成像检测的肿瘤选择性放射增敏剂。
Clin Cancer Res. 1999 Apr;5(4):739-45.
3
Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases.钆特沙卟啉(一种可在磁共振成像中检测到的辐射增敏剂)的1B期和2期多剂量试验:脑转移瘤的初步结果
Radiology. 1999 Sep;212(3):755-9. doi: 10.1148/radiology.212.3.r99se10755.
4
Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.莫替沙芬钆:钆(III)替克卟啉、钆替克卟啉、Gd-Tex、GdT2B2、PCI 0120。
Drugs R D. 2004;5(1):52-7. doi: 10.2165/00126839-200405010-00012.
5
Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.多中心Ib/II期试验:辐射增强剂莫特沙芬钆用于脑转移瘤患者的研究
J Clin Oncol. 2001 Apr 1;19(7):2074-83. doi: 10.1200/JCO.2001.19.7.2074.
6
Gd-Tex Pharmacyclics Inc.吉利德 - 德克斯制药公司(Gd-Tex Pharmacyclics Inc.) 需注意,“Gd-Tex”这种表述可能不太准确,也许是特定的名称缩写,若有更准确的背景信息,翻译会更精准。这里暂且按字面近似翻译。
Curr Opin Investig Drugs. 2000 Dec;1(4):524-8.
7
In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.以钆(III)替克沙卟啉作为辐射增强剂的体内动物研究。
Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):981-9. doi: 10.1016/s0360-3016(99)00274-6.
8
Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent.重新评估钆(III) texaphyrin作为一种放射增敏剂的作用。
Cancer Res. 2000 Jan 1;60(1):86-91.
9
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.莫替沙芬钆与累及野放射治疗儿童脑桥内胶质瘤:儿童肿瘤研究组I期研究
Neuro Oncol. 2008 Oct;10(5):752-8. doi: 10.1215/15228517-2008-043. Epub 2008 Aug 20.
10
Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.多形性胶质母细胞瘤患者中莫替沙芬钆联合标准放疗的I期剂量递增研究结果。
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):831-8. doi: 10.1016/j.ijrobp.2007.04.017. Epub 2007 Jun 8.

引用本文的文献

1
Good MRI images: to Gad or not to Gad?优质的磁共振成像(MRI)图像:用钆对比剂还是不用?
Pediatr Nephrol. 2007 Sep;22(9):1239-42. doi: 10.1007/s00467-007-0509-z. Epub 2007 May 22.